Mitchell Jones - Sep 5, 2023 Form 3 Insider Report for PALISADE BIO, INC. (PALI)

Role
Chief Medical Officer
Signature
/s/ Mitchell Jones
Stock symbol
PALI
Transactions as of
Sep 5, 2023
Transactions value $
$0
Form type
3
Date filed
9/13/2023, 05:20 PM
Previous filing
Feb 8, 2024
Next filing
Nov 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PALI Common Stock Purchase Option Sep 5, 2023 Common Stock 75K $0.69 Direct F1
holding PALI Restricted Stock Units Sep 5, 2023 Common Stock 54.7K $0.00 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an inducement stock option grant issued from the Palisade Bio 2021 Inducement Plan. The options vest quarterly in twelve (12) equal installments over a three (3) year period.
F2 Represents an inducement restricted stock unit grant issued from the Palisade Bio 2021 Inducement Plan. The RSUs vest as follows: (i) 4,556 shares vest on 11/6/2023 and (ii) the remaining 51,144 shares vest in equal installments over the following eleven (11) quarterly periods thereafter.
F3 Each RSU represents a contingent right to receive one share of Issuer's common stock.
F4 N/A.